How robust are the results of one of the first positive trials exploring hydroxychloroquine for treatment of COVID-19?
View ORCID ProfileRonald Chow, Sameer Elsayed, Michael Lock
doi: https://doi.org/10.1101/2020.05.06.20093237
Ronald Chow
Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada
Sameer Elsayed
Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada
MDMichael Lock
Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
N/A
Posted May 11, 2020.
How robust are the results of one of the first positive trials exploring hydroxychloroquine for treatment of COVID-19?
Ronald Chow, Sameer Elsayed, Michael Lock
medRxiv 2020.05.06.20093237; doi: https://doi.org/10.1101/2020.05.06.20093237
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4029)
- Geriatric Medicine (379)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (359)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (563)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6469)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)